About
Company Profile
Management Team
Honors Course
Vision & Mission
Chengdu Biostar
Synthetic Biology
R&D
Pipeline
Clinical Recruitment
Partnering
Cooperative Partners
Business development
IR
Product
Utidelone
Medical consultation and Drug Safety Hotline
News
Contact
Career
Contact
CN
菜单
search
Index
About
Company Profile
Management Team
Honors Course
Vision & Mission
Chengdu Biostar
Synthetic Biology
R&D
Pipeline
Clinical Recruitment
Partnering
Cooperative Partners
Business development
IR
Product
Utidelone
Medical consultation and Drug Safety Hotline
Contact
Career
Contact
news
Company News
all
all
2021
2020
2019
2021-06-28
优替德隆是通过基因工程合成的埃博霉素类似物。
2021-06-28
优替德隆是通过基因工程合成的埃博霉素类似物。
2021-06-28
2020年年度报告
2020
2021-06-28
2020年年度报告
2020
2021-06-28
2021年年度报告
2021
2021-06-28
2020年年度报告
2020
2021-06-28
临床CRA
本科及以上
2021-06-28
A Pivotal Phase II Clinical Trial of Utidelone Injection (UTD1) Plus Capecitabine (CAP) in HER2-negative Breast Cancer Patients with Brain Metastases
2021-06-25
使用条款
2021-06-25
隐私政策
2021-06-25
优替德隆是通过基因工程合成的埃博霉素类似物。
2019
2021-06-25
优替德隆是通过基因工程合成的埃博霉素类似物。
2020
« 上一页
1
2
...
8
9
10
11
12
13
下一页 »